DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» ADAM (protein)
ADAM (protein)
What Are the Roles of Metalloproteinases in Cartilage and Bone Damage? G Murphy, M H Lee
Negatively Regulated by ADAM15 TRIF-Mediated TLR3 and TLR4
ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease
Expression of the Disintegrin Metalloprotease, ADAM-10, In
Antibody Target for Therapeutic Inhibition Of
Endogenous Regulators of Angiogenesis –
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Strategies to Target ADAM17 in Disease: from Its Discovery to the Irhom Revolution
Regulation of Profibrotic Responses by ADAM17 Activation in High Glucose Requires Its C-Terminus and FAK Renzhong Li, Tony Wang, Khyati Walia, Bo Gao and Joan C
Expression of the Disintegrin Metalloprotease, ADAM-10, In
Functional and Structural Studies of the Presequence Protease, Prep
Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact
A Hypothesis for the Role of RECK in Angiogenesis
The Adams Family of Metalloproteases: Multidomain Proteins with Multiple Functions
ADAM8 As a Drug Target in Pancreatic Cancer
Anti-ADAM-15, Propeptide Domain Antibody Produced in Rabbit (A3726
Neprilysin Inhibition in the Time of Precision Medicine∗
A Systematic Study of Modulation of ADAM-Mediated Ectodomain Shedding by Site-Specific O-Glycosylation
Top View
The Role of the Metalloproteases ADAM8, 9, 10 and 17 in Leukocyte Migration in Vitro
ADAM and ADAMTS) Enzymes in Human Non-Small-Cell Lung Carcinomas (NSCLC)
Matrix Metalloproteinases: How Much Can They Do?
Mmps, Adams and Their Natural Inhibitors in Inflammatory Bowel
Relevance of Platelet Desialylation and Thrombocytopenia in Type 2B Von Willebrand Disease: Preclinical and Clinical Evidence
Neprilysin Inhibitors and Bradykinin
Chemotherapy-Induced Activation of ADAM-17: a Novel Mechanism of Drug Resistance in Colorectal Cancer
ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease
Hoofdstuk Proteases and Angiogenesis
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
1 Supplementary Material Figure S1. Volcano Plot of Differentially
ADAM Gene Expression in the Adult CNS and Genetic Aberrations in Cancer Cells
Selective Inhibition of ADAM Metalloproteases As a Novel Approach for Modulating Erbb Pathways in Cancer Jordan S
Dual Roles for Hepatic Lectin Receptors in the Clearance of Chilled Platelets
Activation Specificity of Cpg-Induced Immune CXCL16 Influences The
Organellar Oligopeptidase (OOP) Provides a Complementary Pathway
ADAM Proteases Emerging Role and Targeting of the Non-Catalytic Domains
ADAM and ADAMTS Proteins, New Players in the Regulation Of